Cargando…
Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis
CONTEXT: Pre-clinical evidence suggests that prolactin has important metabolic functions in pregnancy and postpartum, in addition to lactogenic actions. OBJECTIVE: To explore the relationship between prolactin and maternal metabolic outcomes in human pregnancy and postpartum, particularly in relatio...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813437/ https://www.ncbi.nlm.nih.gov/pubmed/36619539 http://dx.doi.org/10.3389/fendo.2022.1069625 |
_version_ | 1784863919716696064 |
---|---|
author | Rassie, Kate Giri, Rinky Joham, Anju E. Mousa, Aya Teede, Helena |
author_facet | Rassie, Kate Giri, Rinky Joham, Anju E. Mousa, Aya Teede, Helena |
author_sort | Rassie, Kate |
collection | PubMed |
description | CONTEXT: Pre-clinical evidence suggests that prolactin has important metabolic functions in pregnancy and postpartum, in addition to lactogenic actions. OBJECTIVE: To explore the relationship between prolactin and maternal metabolic outcomes in human pregnancy and postpartum, particularly in relation to gestational diabetes mellitus (GDM). DATA SOURCES: MEDLINE via OVID, CINAHL plus, Embase. STUDY SELECTION: Eligible studies included women who were pregnant or up to 12 months postpartum, reporting at least one maternal serum prolactin level in relation to key metabolic outcomes including GDM, glycaemic parameters, obesity, and gestational weight gain. DATA EXTRACTION: Two independent reviewers extracted data. DATA SYNTHESIS: Twenty-six articles were included. Meta-analysis showed no relationship between maternal prolactin levels and GDM status, with a weighted mean difference of -2.14 ng/mL (95% CI -12.54 to 8.27 ng/mL, p=0.7) between GDM and controls in early pregnancy (n=3 studies) and -3.89 ng/mL (95% CI, -15.20 to 7.41 ng/mL, p=0.5) in late pregnancy (n=11 studies). In narrative synthesis of other outcomes (due to study heterogeneity and/or lack of data), prolactin levels were not associated with maternal glycaemic or weight-related parameters during pregnancy, but in the postpartum period (particularly with lactation) a high-prolactin environment was associated with low circulating insulin and beta-cell function, and increased insulin sensitivity. CONCLUSIONS: Current evidence from human studies does not clearly support a relationship between prolactin and metabolic parameters during pregnancy, including with GDM status. Elevated prolactin was associated with lower insulin and beta-cell function and higher insulin sensitivity in the post-partum period, but the direction of causality remains unclear. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier [CRD42021262771]. |
format | Online Article Text |
id | pubmed-9813437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98134372023-01-06 Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis Rassie, Kate Giri, Rinky Joham, Anju E. Mousa, Aya Teede, Helena Front Endocrinol (Lausanne) Endocrinology CONTEXT: Pre-clinical evidence suggests that prolactin has important metabolic functions in pregnancy and postpartum, in addition to lactogenic actions. OBJECTIVE: To explore the relationship between prolactin and maternal metabolic outcomes in human pregnancy and postpartum, particularly in relation to gestational diabetes mellitus (GDM). DATA SOURCES: MEDLINE via OVID, CINAHL plus, Embase. STUDY SELECTION: Eligible studies included women who were pregnant or up to 12 months postpartum, reporting at least one maternal serum prolactin level in relation to key metabolic outcomes including GDM, glycaemic parameters, obesity, and gestational weight gain. DATA EXTRACTION: Two independent reviewers extracted data. DATA SYNTHESIS: Twenty-six articles were included. Meta-analysis showed no relationship between maternal prolactin levels and GDM status, with a weighted mean difference of -2.14 ng/mL (95% CI -12.54 to 8.27 ng/mL, p=0.7) between GDM and controls in early pregnancy (n=3 studies) and -3.89 ng/mL (95% CI, -15.20 to 7.41 ng/mL, p=0.5) in late pregnancy (n=11 studies). In narrative synthesis of other outcomes (due to study heterogeneity and/or lack of data), prolactin levels were not associated with maternal glycaemic or weight-related parameters during pregnancy, but in the postpartum period (particularly with lactation) a high-prolactin environment was associated with low circulating insulin and beta-cell function, and increased insulin sensitivity. CONCLUSIONS: Current evidence from human studies does not clearly support a relationship between prolactin and metabolic parameters during pregnancy, including with GDM status. Elevated prolactin was associated with lower insulin and beta-cell function and higher insulin sensitivity in the post-partum period, but the direction of causality remains unclear. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/prospero/, identifier [CRD42021262771]. Frontiers Media S.A. 2022-12-22 /pmc/articles/PMC9813437/ /pubmed/36619539 http://dx.doi.org/10.3389/fendo.2022.1069625 Text en Copyright © 2022 Rassie, Giri, Joham, Mousa and Teede https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Rassie, Kate Giri, Rinky Joham, Anju E. Mousa, Aya Teede, Helena Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis |
title | Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis |
title_full | Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis |
title_fullStr | Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis |
title_full_unstemmed | Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis |
title_short | Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: A systematic review and meta-analysis |
title_sort | prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: a systematic review and meta-analysis |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813437/ https://www.ncbi.nlm.nih.gov/pubmed/36619539 http://dx.doi.org/10.3389/fendo.2022.1069625 |
work_keys_str_mv | AT rassiekate prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis AT giririnky prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis AT johamanjue prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis AT mousaaya prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis AT teedehelena prolactininrelationtogestationaldiabetesandmetabolicriskinpregnancyandpostpartumasystematicreviewandmetaanalysis |